Trial Profile
Effects of a single teriparatide injection on bone turnover markers in postmenopausal Japanese women
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2013
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Postmenopausal osteoporosis
- Focus Biomarker; Therapeutic Use
- 09 Oct 2013 New trial record